The US is likely to lose its measles elimination status this fall. What that means.
A ruling comes in November. The country has held the status since 2000, and 2026 has already produced more cases than any year in three decades.
For how we live.
A ruling comes in November. The country has held the status since 2000, and 2026 has already produced more cases than any year in three decades.
The advisory committee that shaped U.S. immunization policy for decades was replaced, then bypassed. In March a judge stayed the result.
The appeal is moving on an expedited track, with a status report due this month. But CIDRAP's vaccine-policy trackers make a pointed argument: a working committee could exist right now, if HHS chose to seat one.
CDC data through July 2 puts 2026 at 2,170 confirmed cases, just short of all of 2025's 2,289. Ninety-three percent of this year's cases are linked to active outbreaks.
The committee's founding document now asks for a 'balanced range' of expertise rather than vaccine-specific knowledge, and adds review of non-vaccine alternatives to its mandate.
Judge Brian Murphy found the government likely broke two federal laws when it bypassed ACIP and replaced its members. The ruling reverts the childhood schedule and cancels this week's ACIP meeting.
The American Academy of Pediatrics' 2026 schedule covers 18 diseases and carries 12 outside endorsements. The federal schedule signed three weeks earlier lists 11 vaccines for all children.
Eleven vaccines remain recommended for all children. The rest move to risk-based or shared-decision categories, on the strength of a comparison with 20 other countries.
The 5 December directive tells HHS and the CDC to compare the American childhood schedule with those of other wealthy nations, using a count of diseases as its benchmark.
ACIP replaced a recommendation in place since 1991 with individual decision-making for babies born to mothers who test negative. The CDC has not yet adopted it.
Thirty-seven had the necrotising form, of whom 41% died. Just 16% of vaccine-eligible children with encephalopathy had received that season's flu vaccine. There is no national surveillance for the condition.
The recommendation covers people weighing at least 35 kg and rests on two trials in which lenacapavir cut HIV infections by 100% and 96% against background incidence.
The committee meets 18-19 September on COVID-19, hepatitis B and MMRV vaccines. RSV was dropped two days before. Adopted recommendations carry insurance and Vaccines for Children consequences.
A Federal Register notice on 9 June listed eleven vaccine topics and ten scheduled votes over three days. An amended notice on 24 June listed seven topics, three votes and two days.